Pangaea Oncology SA
MAD:PANG

Watchlist Manager
Pangaea Oncology SA Logo
Pangaea Oncology SA
MAD:PANG
Watchlist
Price: 1.5 EUR Market Closed
Market Cap: €54.3m

Wall St Price Targets

PANG Price Targets Summary
Pangaea Oncology SA

There are no price targets for PANG.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Pangaea Oncology SA Competitors:
Price Targets

Revenue
Forecast

14% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-15%
Average Miss
14% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
-15%
Average Miss

Over the last 12 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 3 years is 15%.

Gross Profit
Forecast

8% / Year
Past Growth
27% / Year
Estimated Growth
Estimates Accuracy
-15%
Average Miss
8% / Year
Past Growth
27% / Year
Estimated Growth
Estimates Accuracy
-15%
Average Miss

Over the last 12 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 3 years is 27%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
68%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
68%
Average Beat

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PANG's stock price target?
Not Available

PANG does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Pangaea Oncology SA?
Projected CAGR
15%

Over the last 12 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 3 years is 15%.

What is the Gross Profit forecast for Pangaea Oncology SA?
Projected CAGR
27%

Over the last 12 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 3 years is 27%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett